ChoiceSpine Granted FDA Clearance for New Cervical Spinal Fusion Devices

FDA Logo

ChoiceSpine received FDA 510(k) clearance to market the TIGER SHARKâ„¢ C interbody device with BioBondâ„¢ technology and the BOOMERANGâ„¢ Anterior Cervical Plate (ACP), for use together or separately in cervical spinal fusion.

BOOMERANG instrumentation is designed to allow simultaneous insertion of the BOOMERANG plate with cervical interbodies, such as TIGER SHARK C or STEALTHâ„¢, mimicking a stand-alone ACDF concept and reducing O.R. time. The BOOMERANG ACP features a two-screw configuration and single-step screw blocking mechanism to optimize insertion and fixation.

TIGER SHARK C is a 3D-manufactured titanium alloy interbody created with BioBond organic, porous interbody architecture designed for continuous porosity with an osteoconductive, hydrophilic surface. TIGER SHARK C is available in an assortment of heights with 6° of lordosis to accommodate different cervical anatomical requirements.

JAV

Julie A. Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

RELATED ARTICLES



CONTACT BONEZONE

 

CONTACT BONEZONE